PCC
VIVO

Park Circle Company’s Meridian Bioscience Inc VIVO Stock Holding History

Park Circle Company’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,000
Closed -$18K – 92
2014
Q3 		$18K Sell
1,000
-10,000
-91% -$196K 0.01% 80
2014
Q2 		$227K Buy
+11,000
New +$226K 0.15% 54

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Park Circle Company's VIVO Position: Q4 2014 in Review

Park Circle Company sold out of Meridian Bioscience Inc (VIVO) in Q4 2014, closing a stake of 1,000 shares — an estimated $18K sold.

Park Circle Company first reported a position in VIVO in Q2 2014 and held it in 2 quarters. The position peaked at $227K in Q2 2014. 160 funds tracked by Wall St. Rank hold VIVO as of Q4 2014.

  • Park Circle Company reported no remaining Meridian Bioscience Inc position as of Q4 2014 after selling out during the quarter.
  • Park Circle Company sold 1,000 Meridian Bioscience Inc shares in Q4 2014, an estimated $18K.
  • Park Circle Company first reported a position in Meridian Bioscience Inc in Q2 2014 and held it in 2 quarters.
  • Park Circle Company's Meridian Bioscience Inc position peaked at $227K in Q2 2014.
  • 160 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2014.

Based on Park Circle Company's 13F filing for Q4 2014, filed 28 Jan 2015.